1. Bishop, K. S., L. Blumberg, A. P. Trollip, A. N. Smith, L. Roux, D. F. York, and P. Kiepiela. 2001. Characterisation of the pncA gene in Mycobacterium tuberculosis isolates from Gauteng, South Africa. Int. J. Tuberc. Lung Dis.5:952-957.
2. pncA
Mutations as a Major Mechanism of Pyrazinamide Resistance in
Mycobacterium tuberculosis
: Spread of a Monoresistant Strain in Quebec, Canada
3. Furtado, C., and L. Brum. 2003. Vigilāncia laboratorial da resistência aos antibacilares em Portugal em 2000-2001. Rev. Port. Pneumol.IX:279-291.
4. Heifets, L. B. 1999. Pyrazinamide, p. 668-676. In V. L. Yu, T. C. Merigan, and S. L. Barriere (ed.), Antimicrobial therapy and vaccines. Williams and Wilkins, Baltimore, Md.
5. Hirano, K., M. Takahashi, Y. Kazumi, Y. Fukasawa, and C. Abe. 1997. Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis. Tuber. Lung Dis.78:117-122.